Core Viewpoint - Lepu Medical Technology has received approval from the National Medical Products Administration for its rechargeable implantable deep brain stimulation system, marking a significant achievement in the field of neuroregulation and providing new treatment options for Parkinson's disease patients [1] Company Summary - Lepu Medical's subsidiary, Lepu Medical Electronics Co., Ltd., has developed and received registration approval for a rechargeable implantable deep brain stimulator, implantable deep brain stimulation electrode components, and implantable deep brain stimulation extension lead kits [1] - The successful launch of the rechargeable implantable deep brain stimulation system is expected to enhance the company's competitiveness in the medical device sector and lay a solid foundation for future stable growth [1] Industry Summary - The approval of the new product is a crucial step for the company in establishing its presence in the neuroregulation market, which is increasingly important for treating neurological disorders such as Parkinson's disease [1]
乐普医疗可充电植入式脑深部神经刺激器系统产品获批